X4 Pharmaceuticals, Inc. · GETTEX:48Q0
X4 Pharmaceuticals, Inc. shareholders
As of Sep 30, 2026, 91 institutions reported holding X4 Pharmaceuticals, Inc. Largest: Morgan Stanley, Empery Asset Management, LP and Bain Capital Life Sciences Investors, LLC. New holders, exits, insiders and big stakes, each with its filing.
Shareholders
Institutions
| Holder | Shares | Value | Change vs Jun 30 | Filed |
|---|---|---|---|---|
| Morgan Stanley | 11M | US$31.9M | +1.53M | Nov 13, 2026 |
| Empery Asset Management, LP | 9.73M | US$28.2M | +2.79M | Nov 16, 2026 |
| Bain Capital Life Sciences Investors, LLC | 7.97M | US$23.1M | No change | Nov 16, 2026 |
| Venrock Adviser, LLC | 7.64M | US$22.2M | +5.71M | Nov 16, 2026 |
| Saturn V Capital Management LP | 7.37M | US$21.4M | +393K | Nov 16, 2026 |
| Perceptive Advisors LLC | 7.35M | US$21.3M | −583K | Nov 16, 2026 |
| BlackRock | 5.85M | US$17M | +300K | Nov 13, 2026 |
| Fidelity | 5.49M | US$15.9M | −2.83M | Nov 10, 2026 |
| Vanguard | 4.68M | US$13.6M | −186K | Nov 13, 2026 |
| Deep Track Capital, LP | 4.5M | US$13.1M | −1.38M | Nov 16, 2026 |
| Kalehua Capital Management LLC | 3.72M | US$10.8M | −3.72M | Nov 13, 2026 |
| Rosalind Advisors, Inc. | 3.21M | US$9.32M | No change | Nov 16, 2026 |
| Trails Edge Capital Partners, LP | 2.57M | US$7.46M | No change | Nov 16, 2026 |
| Nantahala Capital Management, LLC | 2.45M | US$7.1M | −2.45M | Nov 13, 2026 |
| Blackstone Inc. | 2.43M | US$7.04M | −255K | Nov 16, 2026 |
| Braidwell LP | 2.34M | US$6.8M | −578K | Nov 16, 2026 |
| Goldman Sachs | 2.34M | US$6.77M | +1.42M | Nov 16, 2026 |
| Affinity Asset Advisors, LLC | 2.06M | US$5.98M | +1.92M | Nov 13, 2026 |
| Geode Capital | 2.05M | US$5.94M | −50,766 | Nov 6, 2026 |
| State Street | 1.73M | US$5.02M | +434K | Nov 12, 2026 |
| Bvf Inc | 1.58M | US$4.57M | −657K | Nov 16, 2026 |
| Samsara Biocapital, LLC | 1.35M | US$3.91M | −47,864 | Nov 16, 2026 |
| Woodline Partners LP | 1M | US$2.9M | No change | Nov 16, 2026 |
| Northern Trust | 628K | US$1.82M | −25,105 | Nov 16, 2026 |
| Verdad Advisers, LP | 323K | US$937K | −28,927 | Nov 16, 2026 |
| Wellington | 289K | US$839K | +237K | Nov 16, 2026 |
| Schwab | 263K | US$764K | +18 | Nov 16, 2026 |
| Integral Health Asset Management, LLC | 250K | US$725K | New | Nov 16, 2026 |
| Russell Investments Group, Ltd. | 213K | US$618K | +206K | Nov 6, 2026 |
| BNY | 205K | US$594K | +8,651 | Nov 5, 2026 |
| Citadel | 150K | US$436K | New | Nov 16, 2026 |
| Stonepine Capital Management, LLC | 150K | US$435K | −74,989 | Nov 13, 2026 |
| Alps Advisors Inc | 130K | US$378K | +34,698 | Nov 2, 2026 |
| Susquehanna | 120K | US$347K | +18,474 | Nov 16, 2026 |
| Invesco | 117K | US$340K | +20,458 | Nov 12, 2026 |
| Renaissance Technologies | 116K | US$335K | +97,424 | Nov 12, 2026 |
| American Century | 114K | US$330K | +38,941 | Nov 20, 2026 |
| Nuveen | 111K | US$322K | +3,668 | Nov 10, 2026 |
| Prudential Financial Inc | 110K | US$318K | +97,205 | Nov 16, 2026 |
| XTX Topco Ltd | 101K | US$292K | New | Nov 16, 2026 |
| Rhumbline Advisers | 94,984 | US$275K | −97 | Nov 10, 2026 |
| Point72 Asset Management, L.P. | 93,565 | US$271K | +52,493 | Nov 16, 2026 |
| Squarepoint Ops LLC | 83,488 | US$242K | +16,410 | Nov 9, 2026 |
| Bank of America | 70,237 | US$204K | +23,376 | Nov 16, 2026 |
| EntryPoint Capital, LLC | 70,147 | US$203K | New | Nov 13, 2026 |
| DWS | 68,976 | US$200K | −9,909 | Nov 6, 2026 |
| Algert Global LLC | 67,553 | US$196K | New | Nov 17, 2026 |
| T. Rowe Price | 66,379 | US$193K | No change | Nov 16, 2026 |
| UBS | 49,642 | US$144K | −8,401 | Nov 16, 2026 |
| Palumbo Wealth Management LLC | 48,373 | US$140K | −18,743 | Nov 12, 2026 |
This page holds 50 of 91 holders.
Funds
This page holds 50 of 74 holders.
Big stakes
| Holder | Stake | Shares | Date |
|---|---|---|---|
| Morgan Stanley | 10.20% | 8.88M | Feb 28, 2026 |
| Coastlands Capital LP | 9.99% | 10.7M | Sep 30, 2026 |
| Empery Asset Management, LP | 9.99% | 9.04M | Dec 31, 2025 |
| Perceptive Advisors LLC | 8.10% | 8.09M | Jun 30, 2026 |
| Venrock Healthcare Capital Partners III, L.P. | 7.60% | 7.64M | Sep 30, 2026 |
| BCLS II Equity Opportunities, LP | 7.43% | 7.05M | Dec 31, 2025 |
| Saturn V Capital Management LP | 7.36% | 6.43M | Oct 24, 2025 |
| Deep Track Capital, LP | 6.58% | 6.66M | Sep 30, 2026 |
| Growth Equity Opportunities 18 VGE, LLC | 6.20% | 5.06M | Oct 27, 2025 |
| BlackRock, Inc. | 5.90% | 5.53M | Jun 30, 2026 |
| Trails Edge Capital Partners, LP | 5.80% | 5.23M | Dec 31, 2025 |